Regulatory requirements for marketing fixed dose combinations
The development of fixed-dose combinations (FDCs) is becoming increasingly important from a public health perspective.FDCs have advantages when there is an identifiable patient population for whom treatment with a particular combination of actives in a fixed ratio is safe Limited Editions and effective and when all of the actives contribute to the